Bremelanotide vs Lixisenatide

Head-to-head comparison of Bremelanotide (Bremelanotide (PT-141), cyclic melanocortin receptor agonist) and Lixisenatide (Exendin-4-derived GLP-1 receptor agonist) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyBremelanotideLixisenatide
CategorySexual HealthWeight Management
Full NameBremelanotide (PT-141), cyclic melanocortin receptor agonistExendin-4-derived GLP-1 receptor agonist
Molecular Weight1025.2 Da4858 Da
Half-Lifeabout 2.7 h2-4 hours
Amino Acids744
Typical Dose1.75 mg10-20 mcg daily
RouteSubcutaneousSubcutaneous
Purity≥98%≥98%
Studies Count200400
Research StatusClinicalApproved

Bremelanotide Benefits

  • increases sexual desire
  • supports arousal
  • may improve erectile response
  • on-demand use

Lixisenatide Benefits

  • postprandial glucose control
  • modest weight loss
  • appetite reduction
  • short-acting option

Bremelanotide Dosing

1.75 mg subcutaneous PRN|administer about 45 minutes before activity|max 1 dose per 24 hours

Lixisenatide Dosing

10 mcg SC daily for 14 days|Increase to 20 mcg daily|Inject before the first meal of the day

Bremelanotide Side Effects

  • nausea
  • flushing
  • headache
  • transient blood pressure increase

Lixisenatide Side Effects

  • nausea
  • vomiting
  • hypoglycemia when combined with insulin

Research Overview

Bremelanotide

Human studies and approval data support meaningful effects on sexual desire in women, with a central mechanism involving melanocortin signaling. It is one of the most clinically relevant peptides in this category and is commonly used as the reference compound for PT-141-type research.

Lixisenatide

Lixisenatide produces small but measurable weight loss in diabetes trials while improving postprandial glucose excursions. Its shorter half-life makes it a useful reference compound for first-generation incretin mimetics.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Bremelanotide stacks with:

Kisspeptin-54Melanotan-II

Lixisenatide stacks with:

basal-insulinmeal-plan
melanocortinlibidoerectile-functionapprovedGLP-1RAshort-actingpostprandial-controlweight-loss-adjacent